Asset
WP-1122
Moleculin Biotech Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05195723 | phase1 | completed | 2022-05-11 | 2022-10-24 | Moleculin Biotech, Inc. | Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers |
FDA applications (0)
This company has no applications containing this asset.